Accessibility Menu
Electromedical Technologies logo

Electromedical Technologies(OTC) EMED

Market Cap$373.20KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2019)-100%
5 Year-100%
1 Year-50%
1 Month+0%
$0.00
+0.00%
+0.00Today
Electromedical Technologies last closing stock price
MetricPriceDate
Last closeUSD 0.002026-08-31
Electromedical Technologies stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-08-24
1 month+0%USD 0.002026-07-30
3 month-50%USD 0.002026-06-02
Year to date-50%USD 0.002025-12-31
1 year-50%USD 0.002025-08-29
3 year-88.57%USD 0.002023-09-01
5 year-99.78%USD 0.052021-09-01
Since inception-99.99%USD 1.502019-08-14

Electromedical Technologies Financials at a Glance

Market Cap

$373.20KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$27.47K

Net Income (TTM)

-$1.72M

EPS (TTM)

-$0.00

P/E Ratio

-0.25

Dividend

$0.00

Beta (Volatility)

-6.41 (Low)

Price

$0.00

Volume

103,076,688

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

EMED News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Electromedical Technologies

Electromedical Technologies, Inc. specializes in the development and distribution of bioelectronic medical devices aimed at pain management. The company is known for its flagship product, WellnessPro Plus, which is utilized by both individuals and healthcare professionals to alleviate various types of pain.

Products and Services
  • WellnessPro Plus: A prescription-based bioelectronic therapy tool
  • Focus on chronic and acute pain management solutions
  • Targeted towards individual users and healthcare providers
Growth Outlook
  • Increasing demand for non-invasive pain management solutions
  • Expansion into new markets anticipated in the coming years
  • Potential for product line diversification to enhance revenue streams
Financial Highlights
  • Recent quarterly revenue of 3,849, showing a slight recovery trend
  • Trailing twelve months (TTM) revenue of 11,744, indicating growth potential
  • Operating expenses remain high, impacting net income negatively
Electromedical Technologies, Inc. operates in the medical devices sector, focusing on innovative solutions for pain management. The company's flagship product, WellnessPro Plus, is designed to provide effective relief for both chronic and acute pain, catering to a growing market that increasingly favors non-invasive treatment options. The growth outlook for Electromedical Technologies appears promising, driven by rising demand for bioelectronic devices and potential market expansion. The company is well-positioned to capitalize on trends favoring non-invasive therapies, which may lead to increased adoption of its products. Financially, the company has shown signs of recovery with a recent quarterly revenue of 3,849, reflecting a slight upward trend. However, the trailing twelve months (TTM) revenue of 11,744 suggests that while growth is possible, challenges remain, particularly with high operating expenses that have negatively impacted net income. Investors may find interest in the company's potential for future growth, especially as it seeks to diversify its product offerings and expand into new markets.
AI Generated • Aug 21, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

6

CEO

Matthew N. Wolfson

Website

www.electromedtech.com

Headquarters

Scottsdale, AZ 85260, US

EMED Financials

Key Financial Metrics (TTM)

Gross Margin

-252.41%

Operating Margin

-4165.36%

Net Income Margin

-6271.25%

Return on Equity

44.04%

Return on Capital

N/A

Return on Assets

-287.99%

Earnings Yield

-4.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$373.20KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

3.73B

Volume

103.08M

Avg. Volume

5.66M

Financials (TTM)

Gross Profit

-$69.32K

Operating Income

-$1.14M

EBITDA

-$1.07M

Operating Cash Flow

-$549.57K

Capital Expenditure

$6.00

Free Cash Flow

-$549.56K

Cash & ST Invst.

$531.00

Total Debt

$1.26M

Electromedical Technologies Performance Analysis

Electromedical Technologies annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 1,149,84426.7%
20232023-12-31USD 1,348,80817.3%
20242024-12-31USD 588,365-56.4%
20252025-12-31USD 41,195-93.0%
Electromedical Technologies sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-308.9%
Q42025-12-3150.9%
Q12026-03-31-67.2%
Q22026-06-306.2%
Electromedical Technologies annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.03-88.8%
20232023-12-31USD -0.01-73.9%
20242024-12-31USD -0.00-71.4%
20252025-12-31USD -0.00-75.0%
Electromedical Technologies sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30N/A
Q42025-12-31N/A
Q12026-03-31N/A
Q22026-06-30N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$4.09K

-42.8%

Gross Profit

-$21.10K

-189.0%

Gross Margin

-5.16%

N/A

Market Cap

$373.20KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$62.20K

N/A

Employees

6

N/A

Net Income

-$333.22K

-209.3%

EBITDA

-$252.00K

-175.3%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$531.00

-25.7%

Total Debt

$1.26M

+61.7%

Accounts Receivable

$11.52K

+52.2%

Inventory

$25.91K

+26.4%

Long Term Debt

$150.01K

-9.7%

Short Term Debt

$1.11M

+81.0%

Return on Assets

-2.88%

N/A

Return on Invested Capital

27.57%

N/A

Free Cash Flow

-$116.22K

-245.6%

Operating Cash Flow

-$116.22K

-245.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BNYNBanyan Corp.
$0.00+0.00%
CBDLCBD Life Sciences Inc.
$0.00-50.00%
BLFEBioLife Sciences Inc.
$0.00+0.00%
HPMMHemp Naturals, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About EMED

What is the current price of Electromedical Technologies?

Electromedical Technologies is trading at $0.00 per share.

What is the 52-week range for Electromedical Technologies?

Over the past 52 weeks, Electromedical Technologies has traded between $0.00 and $0.00.

How much debt does Electromedical Technologies have?

As of the most recent reporting period, Electromedical Technologies reported total debt of $1.26M.

How much cash does Electromedical Technologies have on hand?

Electromedical Technologies reported $531.00 in cash and cash equivalents in its most recent financial results.

What is Electromedical Technologies’s dividend yield?

Electromedical Technologies does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services